Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Chiara Liverani
Observed names:
C Liverani,
C. Liverani,
C. Liverani,
CHIARA LIVERANI,
Chiara, Liverani,
Liverani, C.,
Liverani, Chiara,
Liverani,Chiara
show all 8
Institution:
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
Observed institutions:
Houston Methodist,
Azienda Ospedaliera San Giovanni Addolorata,
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori,
Ospedale G.B. Morgagni - L.Pierantoni,
Houston Methodist Research Institute,
University of Bologna
show all 6
ORCID:
0000-0002-4279-1926
Observed ORCID:
0000-0002-4279-1926
OpenAlex ID:
A5016193335
Biomimetic Tissue Engineering: Tuning the Immune and Inflammatory Response to Implantable Biomaterials
2018
·
Francesca Taraballi
, Manuela Sushnitha
, et al.
·
Advanced Healthcare Materials
·
131
Management and potentialities of primary cancer cultures in preclinical and translational studies
2017
·
Giacomo Miserocchi
, Laura Mercatali
, et al.
·
Journal of Translational Medicine
·
129
PDF
Development of a Patient-Derived Xenograft (PDX) of Breast Cancer Bone Metastasis in a Zebrafish Model
2016
·
Laura Mercatali
, Federico La Manna
, et al.
·
International Journal of Molecular Sciences
·
110
PDF
Current classification, treatment options, and new perspectives in the management of adipocytic sarcomas
2016
·
Alessandro De Vita
, Laura Mercatali
, et al.
·
OncoTargets and Therapy
·
106
A biomimetic 3D model of hypoxia-driven cancer progression
2019
·
Chiara Liverani
, Alessandro De Vita
, et al.
·
Scientific Reports
·
99
PDF
Non-invasive imaging of Young’s modulus and Poisson’s ratio in cancers in vivo
2020
·
Md. Tauhidul Islam
, Songyuan Tang
, et al.
·
Scientific Reports
·
93
PDF
Myxofibrosarcoma landscape: diagnostic pitfalls, clinical management and future perspectives
2022
·
Silvia Vanni
, Alessandro De Vita
, et al.
·
Therapeutic Advances in Medical Oncology
·
90
Lysyl oxidase engineered lipid nanovesicles for the treatment of triple negative breast cancer
2021
·
Alessandro De Vita
, Chiara Liverani
, et al.
·
Scientific Reports
·
82
PDF
Investigating the Mechanobiology of Cancer Cell–ECM Interaction Through Collagen-Based 3D Scaffolds
2017
·
Chiara Liverani
, Laura Mercatali
, et al.
·
Cellular and Molecular Bioengineering
·
73
The potential role of the extracellular matrix in the activity of trabectedin in UPS and L-sarcoma: evidences from a patient‐derived primary culture case series in tridimensional and zebrafish models
2021
·
Alessandro De Vita
, Federica Recine
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
52
PDF
A Rationale for the Activity of Bone Target Therapy and Tyrosine Kinase Inhibitor Combination in Giant Cell Tumor of Bone and Desmoplastic Fibroma: Translational Evidences
2022
·
Alessandro De Vita
, Silvia Vanni
, et al.
·
Biomedicines
·
51
PDF
Three-dimensional collagen-based scaffold model to study the microenvironment and drug-resistance mechanisms of oropharyngeal squamous cell carcinomas
2021
·
Giacomo Miserocchi
, Claudia Cocchi
, et al.
·
Cancer Biology and Medicine
·
51
Diagnostic and Predictive Role of DLL3 Expression in Gastroenteropancreatic Neuroendocrine Neoplasms
2021
·
Chiara Liverani
, Alberto Bongiovanni
, et al.
·
Endocrine Pathology
·
49
Primary Culture of Undifferentiated Pleomorphic Sarcoma: Molecular Characterization and Response to Anticancer Agents
2017
·
Alessandro De Vita
, Federica Recine
, et al.
·
International Journal of Molecular Sciences
·
47
PDF
CSF-1 blockade impairs breast cancer osteoclastogenic potential in co-culture systems
2014
·
Chiara Liverani
, Laura Mercatali
, et al.
·
Bone
·
43
Outcome Analysis of First-line Somatostatin Analog Treatment in Metastatic Pulmonary Neuroendocrine Tumors and Prognostic Significance of 18FDG-PET/CT
2016
·
Alberto Bongiovanni
, Federica Recine
, et al.
·
Clinical Lung Cancer
·
42
Myxofibrosarcoma primary cultures: molecular and pharmacological profile
2017
·
Alessandro De Vita
, Federica Recine
, et al.
·
Therapeutic Advances in Medical Oncology
·
41
PDF
First-line chemotherapy in patients with metastatic gastroenteropancreatic neuroendocrine carcinoma
2015
·
Alberto Bongiovanni
, Nada Riva
, et al.
·
OncoTargets and Therapy
·
41
PDF
Precision Medicine in Head and Neck Cancers: Genomic and Preclinical Approaches
2022
·
Giacomo Miserocchi
, Chiara Spadazzi
, et al.
·
Journal of Personalized Medicine
·
39
PDF
Perfusion Flow Enhances Viability and Migratory Phenotype in 3D-Cultured Breast Cancer Cells
2021
·
Alice Pasini
, Joseph Lovecchio
, et al.
·
Annals of Biomedical Engineering
·
39
PDF
Unveiling the Genomic Basis of Chemosensitivity in Sarcomas of the Extremities: An Integrated Approach for an Unmet Clinical Need
2023
·
Silvia Vanni
, Valentina Fausti
, et al.
·
International Journal of Molecular Sciences
·
38
PDF
Combining preclinical tools and models to unravel tumor complexity: Jump into the next dimension
2023
·
Giacomo Miserocchi
, Martine Bocchini
, et al.
·
Frontiers in Immunology
·
37
PDF
Update on the role of trabectedin in the treatment of intractable soft tissue sarcomas
2017
·
Federica Recine
, Alberto Bongiovanni
, et al.
·
OncoTargets and Therapy
·
37
PDF
Clinical and translational implications of immunotherapy in sarcomas
2024
·
Federica Recine
, Silvia Vanni
, et al.
·
Frontiers in Immunology
·
36
Deciphering the Genomic Landscape and Pharmacological Profile of Uncommon Entities of Adult Rhabdomyosarcomas
2021
·
Alessandro De Vita
, Silvia Vanni
, et al.
·
International Journal of Molecular Sciences
·
36
PDF
Show more works
View as search
Works count:
150
Citation count:
2,595
H-index:
32
I10-index:
67
Year
Topic
Type